# NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)

Federal grant opportunity, via Kontrakk.

- **Agency:** National Institutes of Health
- **Opportunity number:** PAR-25-026
- **Status:** posted
- **Opens:** December 5, 2024
- **Closes:** January 7, 2027
- **CFDA:** 93.840, 93.233, 93.839, 93.837, 93.838
- **View on Kontrakk:** https://kontrakk.com/grants/357543

## Description

No description provided.